🔎 Trials Near Me

Gara Jalqabaatti › Kansera Urogenital › Tennessee › Nashville

Qorannoo klinikaalii Kansera Urogenital Nashville, TN keessatti

Qorannoo 5 Kansera Urogenital f Nashville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Namoota walitti qabaa jiraSadarkaa 3
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07566156

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05874921

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sarah Cannon Research Institute, Nashville
  • Urology Associates, Nashville
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06800313

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

Qorannoo Kansera Urogenital magaalota biroo keessatti

Qorannoo biroo Nashville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.